Introducing Shimadzu’s MultiNA II: Redefining precision in life science analysis

Designed with users in mind, the MultiNA II MCE-301 is a fully automated microchip electrophoresis system designed to accelerate and simplify genetic analysis workflows in pharmaceutical and biopharmaceutical laboratories.

This award winning, compact system streamlines nucleic acid electrophoresis - traditionally a process requiring more than two hours of manual preparation - by fully automating steps such as gel preparation, reagent handling, sample loading, separation and detection. Users can initiate analysis by simply registering samples, loading reagents and pressing start.

Building on the previous MultiNA platform, the new model introduces advanced RNA and DNA analysis capabilities, including RNA Integrity Index (RII) calculation, automated DNA fingerprinting and grouping analysis functions. With detection sensitivity reaching 5 pg/μL, the system supports high-precision analysis of low-concentration samples.

New functionality broadens its application scope across biopharma workflows, including quality control of next-generation sequencing libraries, total RNA assessment, mRNA purity verification, mutation detection in genome editing, and genotyping.

In addition to performance improvements, the MultiNA II MCE-301 enhances laboratory sustainability, reducing power consumption by 70% and pure water usage by 60% compared with earlier models. MultiNA II is a high-efficiency, environmentally conscious solution for modern genetic analysis.

The MultiNA II MCE-301 combines cutting-edge sensitivity and expanded analysis capabilities with intuitive, fully automated operation - delivering faster, more reliable results while reducing laboratory resource use. Its versatile applications make it an ideal choice for pharmaceutical and biopharmaceutical labs seeking to accelerate discovery and ensure data integrity, all within a smaller environmental footprint.